Roberto Ravasio
Impact in
Papers in ⓘ
-
- Health Systems, Economic Evaluations, Quality of Life 18
- Pharmaceutical Economics and Policy 10
- Immunology 23
- Biosimilars and Bioanalytical Methods 16
- Co-authors
- Alessia Marelli (1 shared paper)Rino Micheloni (1 shared paper)Carlo Lucioni (6 shared papers)G Chirico (2 shared papers)Felicetto Ferrara (1 shared paper)Giovanni Di Minno (2 shared papers)Mario Guidotti (1 shared paper)Carlo Dani (1 shared paper)
- Journals
- Value in Health (4 papers)ClinicoEconomics and Outcomes Research (3 papers)Advances in Therapy (2 papers)Journal of Neuromuscular Diseases (1 paper)Current Medical Research and Opinion (1 paper)
- Partner nations
- ItalyNetherlandsUnited States
In The Last Decade
Roberto Ravasio
80 papers receiving 390 citations
Peers
Comparison fields: 5 of 82
- Hardware and Architecture 28
- Hepatology 27
- Genetics 34
- Rheumatology 47
- Computer Networks and Communications 66
Countries citing papers authored by Roberto Ravasio
This map shows the geographic impact of Roberto Ravasio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Ravasio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Ravasio more than expected).
Fields of papers citing papers by Roberto Ravasio
This network shows the impact of papers produced by Roberto Ravasio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Ravasio. The network helps show where Roberto Ravasio may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Ravasio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 68 | |
| 2 | 2009 | 27 | |
| 3 | 2008 | 26 | |
| 4 | 2007 | 22 | |
| 5 | 2003 | 17 | |
| 6 | 2012 | 16 | |
| 7 | 2016 | 15 | |
| 8 | 2004 | 15 | |
| 9 | 2015 | 13 | |
| 10 | 2016 | 12 | |
| 11 | 2014 | 11 | |
| 12 | 2011 | 11 | |
| 13 | 2013 | 10 | |
| 14 | 2021 | 9 | |
| 15 | 2006 | 9 | |
| 16 | 2009 | 7 | |
| 17 | 2015 | 6 | |
| 18 | 2017 | 5 | |
| 19 | 2008 | 5 | |
| 20 | 2009 | 5 |
About Roberto Ravasio
Roberto Ravasio is a scholar working on Economics and Econometrics, Immunology, Pulmonary and Respiratory Medicine, Epidemiology and Surgery, having authored 99 papers that have together received 413 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (18 papers), Biosimilars and Bioanalytical Methods (16 papers), Pharmaceutical Economics and Policy (10 papers), Chronic Lymphocytic Leukemia Research (7 papers), Lung Cancer Treatments and Mutations (7 papers), Rheumatoid Arthritis Research and Therapies (6 papers), Schizophrenia research and treatment (6 papers) and Treatment of Major Depression (6 papers). The work is most often cited by research in Hardware and Architecture (28 citations), Hepatology (27 citations), Genetics (34 citations), Rheumatology (47 citations) and Computer Networks and Communications (66 citations). Roberto Ravasio has collaborated with scholars based in Italy, Netherlands and United States. Frequent co-authors include Alessia Marelli, Rino Micheloni, Carlo Lucioni, G Chirico, Felicetto Ferrara, Giovanni Di Minno, Mario Guidotti, Carlo Dani, Serena Pecchioli and Francesco Mazzoleni. Their work appears in journals such as Value in Health, ClinicoEconomics and Outcomes Research, Advances in Therapy, Journal of Neuromuscular Diseases and Current Medical Research and Opinion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.